Hudson Bay Capital Management
NMTR

Hudson Bay Capital Management’s 9 Meters Biopharma NMTR Stock Holding History

Hudson Bay Capital Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,001
Closed -$31.5K – 1126
2022
Q4 		$31.5K Buy
+25,001
New +$57K ﹤0.01% 794

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hudson Bay Capital Management's NMTR Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of 9 Meters Biopharma (NMTR) in Q1 2023, closing a stake of 25,001 shares — an estimated $31.5K sold.

Hudson Bay Capital Management first reported a position in NMTR in Q4 2022 and held it in 1 quarter. The position peaked at $31.5K in Q4 2022. 39 funds tracked by Wall St. Rank hold NMTR as of Q1 2023.

  • Hudson Bay Capital Management reported no remaining 9 Meters Biopharma position as of Q1 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 25,001 9 Meters Biopharma shares in Q1 2023, an estimated $31.5K.
  • Hudson Bay Capital Management first reported a position in 9 Meters Biopharma in Q4 2022 and held it in 1 quarter.
  • Hudson Bay Capital Management's 9 Meters Biopharma position peaked at $31.5K in Q4 2022.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.